Physician Wealth Advisors’s RxSight RXST Stock Holding History

Physician Wealth Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-53	Closed	-$477	–	2136
2025 Q3	$477	Buy	+53	New	+$465	﹤0.01%	1829

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Physician Wealth Advisors's RXST Position: Q4 2025 in Review

Physician Wealth Advisors sold out of RxSight (RXST) in Q4 2025, closing a stake of 53 shares — an estimated $477 sold.

Physician Wealth Advisors first reported a position in RXST in Q3 2025 and held it in 1 quarter. The position peaked at $477 in Q3 2025. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

Physician Wealth Advisors reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
Physician Wealth Advisors sold 53 RxSight shares in Q4 2025, an estimated $477.
Physician Wealth Advisors first reported a position in RxSight in Q3 2025 and held it in 1 quarter.
Physician Wealth Advisors's RxSight position peaked at $477 in Q3 2025.
163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.